Alpha Teknova, Inc. (TKNO) vs Tilray Brands, Inc. (TLRY)

Alpha Teknova, Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Alpha Teknova, Inc. is the larger, with a market value of $486.2M against $415.3M — 1.2× the size. Tilray Brands, Inc. grew revenue faster over the last twelve months: 15.9% against 15.5%. Tilray Brands, Inc. has the higher net margin (−17.1% vs −34.8%) and the higher return on invested capital (−3.21% vs −16.6%). Across the 18 metrics below, Tilray Brands, Inc. leads on 12 and Alpha Teknova, Inc. on 6.

Valuation

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 9.15 0.39 2.08
P/B 7.03 0.23 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 9.17 0.52 2.87
Earnings yield (3.70%) (49.82%) (15.94%)
Free cash flow yield (1.52%) (49.10%) 0.00%

Profitability

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Gross margin 36.43% 29.12% 53.51%
Operating margin (32.65%) (9.26%) 0.00%
Net margin (34.76%) (17.05%) (2.45%)
Free cash flow margin (13.89%) (19.10%) 0.00%
Return on equity (24.12%) (10.50%) (0.80%)
Return on assets (15.79%) (7.45%) (1.67%)
Return on invested capital (16.60%) (3.21%) 0.00%

Growth

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 15.45% 15.93% 5.22%
EPS growth (last fiscal year) 43.86% 95.57% 42.91%
Revenue growth, 5-year CAGR 5.30% 7.82% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Debt to equity 0.22 0.22 0.04
Current ratio 3.56 1.88 2.41
Net debt to EBITDA 0.75 11.34 1.01

Dividend

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Market cap 486.22m 415.28m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack